CSIMarket
 


Qrons Inc   (QRON)
Other Ticker:  
 
 

QRON's Net Income Growth by Quarter and Year

Qrons Inc 's Net Income results by quarter and year




QRON Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - -0.18 -0.95 -0.79
III Quarter September -0.06 -0.53 0.08 -0.08
II Quarter June -0.11 -0.01 0.07 0.03
I Quarter March -0.04 -0.07 -0.26 -0.24
FY   -0.21 -0.79 -1.06 -1.08



QRON Net Income third quarter 2024 Y/Y Growth Comment
Qrons Inc in the third quarter 2024 recorded net loss of $ -0.06 millions.

According to the results reported in the third quarter 2024, Qrons Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Qrons Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2024.




QRON Net Income ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - 133.33 % -
I Quarter March - - - -
FY   - - - -

Financial Statements
Qrons Inc 's third quarter 2024 Net Income $ -0.06 millions QRON's Income Statement
Qrons Inc 's third quarter 2023 Net Income $ -0.53 millions Quarterly QRON's Income Statement


QRON Net Income (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - 14.29 % -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Qrons Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QRON's III. Quarter Q/Q Net Income Comment
Even if Qrons Inc in the III. Quarter 2024 showed net loss of $ -0.06 millions, it should be mentioned, that current results point to recovery compare to the -0.11 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Qrons Inc achieved highest sequential Net Income growth. While Qrons Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QRON's III. Quarter Q/Q Net Income Comment
Despite the fact, that Qrons Inc in the III. Quarter 2024 showed net loss of $ -0.06 millions, management mentioned, that current results are recovery relative to the -0.11 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Qrons Inc achieved highest sequential Net Income growth. While Qrons Inc 's Net Income growth quarter on quarter, overall rank is .


Qrons Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
Cumulative Net Income 12 Months Ending $ -0.39 $ -0.86 $ -0.76 $ -0.79 $ -1.56
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #


Cumulative Net Income growth Comment


Qrons Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Qrons Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
QRON's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for QRON's Competitors
Net Income Growth for Qrons Inc 's Suppliers
Net Income Growth for QRON's Customers

You may also want to know
QRON's Annual Growth Rates QRON's Profitability Ratios QRON's Asset Turnover Ratio QRON's Dividend Growth
QRON's Roe QRON's Valuation Ratios QRON's Financial Strength Ratios QRON's Dividend Payout Ratio
QRON's Roa QRON's Inventory Turnover Ratio QRON's Growth Rates QRON's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2024
Iradimed Corporation-0.35%$ -0.349 millions
Lantheus Holdings Inc -0.65%$ -0.655 millions
Docgo Inc -1.83%$ -1.829 millions
Pacific Health Care Organization Inc-2.38%$ -2.377 millions
Option Care Health Inc -4.34%$ -4.344 millions
Davita Inc -4.40%$ -4.396 millions
Align Technology inc -4.50%$ -4.500 millions
Iqvia Holdings Inc -5.94%$ -5.941 millions
Boston Scientific Corporation-7.14%$ -7.143 millions
Masimo Corp-7.55%$ -7.547 millions
Labcorp Holdings Inc -7.63%$ -7.625 millions
Carlisle Companies Incorporated-8.02%$ -8.020 millions
Pediatrix Medical Group Inc -9.12%$ -9.116 millions
Abbvie Inc -12.18%$ -12.184 millions
West Pharmaceutical Services Inc -15.69%$ -15.685 millions
Amphastar Pharmaceuticals Inc -17.86%$ -17.864 millions
Charles River Laboratories International inc -20.14%$ -20.138 millions
Enzon Pharmaceuticals inc -20.87%$ -20.872 millions
Dariohealth Corp -21.62%$ -21.625 millions
Fonar Corporation-25.37%$ -25.373 millions
National Research Corporation-27.78%$ -27.781 millions
Henry Schein Inc -30.77%$ -30.769 millions
Privia Health Group Inc -33.05%$ -33.053 millions
Merck and Co Inc -33.45%$ -33.453 millions
Bio techne Corp-34.11%$ -34.109 millions
Progyny Inc -34.45%$ -34.451 millions
Amedisys Inc-35.53%$ -35.532 millions
Bristol myers Squibb Company-37.18%$ -37.177 millions
Incyte Corporation-37.84%$ -37.843 millions
Alpha Pro Tech Ltd -39.75%$ -39.754 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com